Kesselheim AS - Search Results

1

Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.

Yeh JS, Sarpatwari A, Kesselheim AS. Yeh JS, et al. Among authors: kesselheim as. Drug Saf. 2016 Aug;39(8):709-14. doi: 10.1007/s40264-016-0419-8. Drug Saf. 2016. PMID: 27000800

2

The rise and fall of Natrecor for congestive heart failure: implications for drug policy.

Kesselheim AS, Fischer MA, Avorn J. Kesselheim AS, et al. Health Aff (Millwood). 2006 Jul-Aug;25(4):1095-102. doi: 10.1377/hlthaff.25.4.1095. Health Aff (Millwood). 2006. PMID: 16835191

3

Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.

Kesselheim AS, Mello MM. Kesselheim AS, et al. Health Aff (Millwood). 2007 Mar-Apr;26(2):483-91. doi: 10.1377/hlthaff.26.2.483. Health Aff (Millwood). 2007. PMID: 17339677 Review.

4

Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety.

Kesselheim AS. Kesselheim AS. Clin Pharmacol Ther. 2010 Jun;87(6):645-7. doi: 10.1038/clpt.2009.213. Clin Pharmacol Ther. 2010. PMID: 20485322

5

Ethical considerations in orphan drug approval and use.

Kesselheim AS. Kesselheim AS. Clin Pharmacol Ther. 2012 Aug;92(2):153-5. doi: 10.1038/clpt.2012.92. Clin Pharmacol Ther. 2012. PMID: 22814660

6

Ethical issues in new drug prescribing.

Cole LW, Kesselheim JC, Kesselheim AS. Cole LW, et al. Among authors: kesselheim jc, kesselheim as. J Bioeth Inq. 2012 Mar;9(1):77-83. doi: 10.1007/s11673-011-9342-y. Epub 2011 Dec 15. J Bioeth Inq. 2012. PMID: 23180203

7

Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs.

Kesselheim AS, Franklin JM, Avorn J, Duke JD. Kesselheim AS, et al. BMJ Qual Saf. 2013 Sep;22(9):727-34. doi: 10.1136/bmjqs-2012-001704. Epub 2013 Apr 25. BMJ Qual Saf. 2013. PMID: 23620531

8

Clinical and regulatory features of drugs not initially approved by the FDA.

Wang B, Avorn J, Kesselheim AS. Wang B, et al. Among authors: kesselheim as. Clin Pharmacol Ther. 2013 Dec;94(6):670-7. doi: 10.1038/clpt.2013.165. Epub 2013 Aug 20. Clin Pharmacol Ther. 2013. PMID: 23963252 Review.

9

Same song, different audience: pharmaceutical promotion targeting non-physician health care providers.

Yeh JS, Kesselheim AS. Yeh JS, et al. Among authors: kesselheim as. PLoS Med. 2013 Nov;10(11):e1001560. doi: 10.1371/journal.pmed.1001560. Epub 2013 Nov 26. PLoS Med. 2013. PMID: 24302891 Free PMC article. No abstract available.

10

Using a drug-safety tool to prevent competition.

Sarpatwari A, Avorn J, Kesselheim AS. Sarpatwari A, et al. Among authors: kesselheim as. N Engl J Med. 2014 Apr 17;370(16):1476-8. doi: 10.1056/NEJMp1400488. N Engl J Med. 2014. PMID: 24738666 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

708 results

Search Page